LSB
Price:
$1.07
Market Cap:
$147.31M
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Industry
Biotechnology
IPO Date
2021-08-05
Stock Exchange
NASDAQ
Ticker
LSB
According to LakeShore Biopharma Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -0.37. This represents a change of -97.45% compared to the average of -14.50 of the last 4 quarters.
The mean historical PE Ratio of LakeShore Biopharma Co., Ltd over the last ten years is -8363.21. The current -0.37 PE Ratio has changed -99.56% with respect to the historical average. Over the past ten years (40 quarters), LSB's PE Ratio was at its highest in in the September 2022 quarter at 1.27K. The PE Ratio was at its lowest in in the December 2022 quarter at -202.52.
Average
-8363.21
Median
-75.79
Minimum
-33288.33
Maximum
-12.93
Discovering the peaks and valleys of LakeShore Biopharma Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.66%
Maximum Annual PE Ratio = -12.93
Minimum Annual Increase = -99.82%
Minimum Annual PE Ratio = -33288.33
Year | PE Ratio | Change |
---|---|---|
2024 | -12.93 | -77.89% |
2023 | -58.47 | -99.82% |
2022 | -33288.33 | 35.66% |
The current PE Ratio of LakeShore Biopharma Co., Ltd (LSB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11119.91
5-year avg
-8363.21
10-year avg
-8363.21
LakeShore Biopharma Co., Ltd’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LakeShore Biopharma Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LakeShore Biopharma Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is LakeShore Biopharma Co., Ltd's PE Ratio?
How is the PE Ratio calculated for LakeShore Biopharma Co., Ltd (LSB)?
What is the highest PE Ratio for LakeShore Biopharma Co., Ltd (LSB)?
What is the 3-year average PE Ratio for LakeShore Biopharma Co., Ltd (LSB)?
What is the 5-year average PE Ratio for LakeShore Biopharma Co., Ltd (LSB)?
How does the current PE Ratio for LakeShore Biopharma Co., Ltd (LSB) compare to its historical average?